• Fusobacterium nucleatum Vesicles Promote CRC Colonization

  2026-07-22

  This study reveals that extracellular vesicles from Fusobacterium nucleatum (FnEVs) are enriched in colorectal cancer tissue, facilitating bacterial adhesion and colonization. These findings elucidate a vesicle-mediated mechanism underlying tumor-microbiome interactions and suggest new experimental approaches for dissecting bacterial niche formation in cancer.

• EZ Cap™ Cas9 mRNA (m1Ψ): Precision Control in Genome Editing

  2026-07-22

  Explore how EZ Cap™ Cas9 mRNA (m1Ψ) redefines precision genome editing with Cap1 structure and m1Ψ modification, offering new insights into temporal Cas9 control and assay design. Discover unique strategies for minimizing off-target effects and optimizing mRNA delivery.

• Standardized Whole-Blood Stimulation: Metabolic Modulation P

  2026-07-21

  This protocol study establishes a standardized method for analyzing immune responses in human whole blood under defined metabolic modulations. By integrating metabolic inhibitors and robust cytokine quantification, the protocol enables precise and reproducible examination of immunometabolic interactions, with broad implications for translational immunology and metabolic disorder research.

• Ultrasound-Triggered Piezo-Nanoplatforms for Epilepsy Therap

  2026-07-21

  This study introduces a biomimetic piezoelectric nanoplatform capable of converting ultrasound stimulation into localized electrical signals for non-invasive neuromodulation in epilepsy. The dual-functional system also enables targeted antiepileptic drug delivery, offering a synergistic approach to seizure control while minimizing surgical risk and systemic side effects.

• FerroOrange Fe²⁺ Indicator: Unveiling Intracellular Iron Dyn

  2026-07-20

  Discover how the FerroOrange Fe²⁺ fluorescent probe empowers advanced, quantitative live-cell iron detection in neuronal systems. This article uniquely bridges mechanistic insights from stroke research with precision assay strategies for intracellular iron detection.

• Lycopene Mitigates DON-Induced Gut Barrier Dysfunction via E

  2026-07-20

  This study identifies lycopene as a protective agent against deoxynivalenol (DON)-induced intestinal barrier dysfunction and NLRP3 inflammasome activation in IPEC-J2 cells, acting through ERK pathway inhibition. The findings suggest therapeutic potential for lycopene in managing mycotoxin-induced gut injury and highlight the mechanistic role of ERK signaling in intestinal inflammation.

• Tiamulin (Thiamutilin) in Veterinary Research: Protocols & O

  2026-07-19

  Tiamulin (Thiamutilin) stands apart as both a pleuromutilin antibiotic and an anti-inflammatory agent for veterinary research, supporting robust disease modeling and translational workflows. This guide details practical protocol parameters, comparative advantages, and troubleshooting strategies to maximize experimental reproducibility and data quality.

• α-Bungarotoxin for Targeted Nicotinic Receptor Blockade in R

  2026-07-18

  α-Bungarotoxin enables precise, selective nicotinic receptor blockade, unlocking advanced models of cholinergic neurotransmission inhibition and necroptosis. Recent translational studies highlight its unique value in both neural and placental signaling research, with workflow refinements and troubleshooting strategies that set it apart from conventional antagonists.

• Lamotrigine in Cardiac and CNS Research: Applied Workflows

  2026-07-17

  Lamotrigine’s dual action as a sodium channel blocker and serotonin inhibitor provides unique leverage for both epilepsy and cardiac arrhythmia modeling. Learn how to optimize protocols and avoid common pitfalls in advanced iPSC-derived cardiomyocyte assays and CNS workflows.

• L-Phenylephrine in Translational Cardiovascular Research: Fr

  2026-07-17

  Explore how L-Phenylephrine, a highly selective adrenergic α1A receptor agonist, enables the next generation of translational cardiovascular and neurobiological research. This thought-leadership article interweaves mechanistic insight, experimental best practices, and strategic guidance for researchers seeking to model disease, interrogate sex differences, and advance the rigor and reproducibility of their work.

• Lamotrigine in Cardiac Sodium Channel Modulation Research

  2026-07-16

  Lamotrigine, a high-purity sodium channel blocker and 5-HT inhibitor, is redefining experimental workflows in neurocardiac research. This article translates cutting-edge findings and practical troubleshooting tips into actionable guidance for leveraging Lamotrigine in high-throughput cardiotoxicity and epilepsy-induced arrhythmia studies.

• Tamsulosin: Mechanisms, Protocols, and Evidence in Urologica

  2026-07-16

  Tamsulosin is a selective α₁A-adrenergic receptor antagonist with robust evidence supporting its use in urological disease research. It facilitates smooth muscle relaxation, improves urinary flow, and is highly soluble in DMSO for laboratory workflows. APExBIO provides a rigorously characterized form (SKU C6445) for translational and preclinical applications.

• Meropenem Trihydrate: Metabolomics-Driven Innovations in Ant

  2026-07-15

  Explore how Meropenem trihydrate enables cutting-edge metabolomics studies of antibiotic resistance phenotypes. This article uniquely bridges molecular mechanisms and translational research, providing actionable insights for advanced bacterial infection treatment research.

• Mianserin HCl: Integrative Insights into 5-HT2 Antagonism an

  2026-07-15

  Explore the multifaceted scientific profile of Mianserin HCl, a 5-HT2 receptor antagonist, with unique insights into its pharmacology, experimental protocols, and cross-domain research potential. This article offers a deeper, evidence-based perspective for advanced antidepressant and antipathogenic studies.

• Cholesterol’s Pivotal Role in Next-Gen mRNA-LNP Therapies

  2026-07-14

  This thought-leadership article explores how the principal sterol, cholesterol, underpins the design, function, and translational impact of lipid nanoparticles (LNPs) for mRNA delivery in bladder cancer therapy. Drawing on recent breakthroughs in intravesical p21 mRNA–LNP treatment, we bridge mechanistic insight with actionable guidance for translational researchers, highlighting APExBIO’s high-purity cholesterol as a strategic enabler in lipid metabolism research and membrane engineering.

15986 records 1/1066 page Next 12345 下5页 Last page